CLOV vs ALHC
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 23, 2026
CLOV
ALHC
Investment Advisor Scores
ALHC
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CLOV | ALHC | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 81.9672 | 204.0816 | CLOV |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 55.6% | 31.6% | CLOV |
| Earnings Growth | 0.0% | 142.9% | ALHC |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 34.3/100 | 56.0/100 | ALHC |
| Profit Margin | -0.7% | 0.9% | ALHC |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | SELL | HOLD | ALHC |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CLOV
NeutralMixed signals - no dominant trend phase, RSI 46
ALHC
MarkdownPrice below a falling SMA50 (slope -6.5%), weak momentum, RSI 38
Fundamentals Snapshot
| Metric | CLOV | ALHC |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 28.2 | 18.0 |
| Trailing P/E | — | 73.2 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.6% | 0.3% |
| Gross Margin | 0.2% | 0.1% |
| Operating Margin | 0.0% | 0.0% |
| EPS | -0.05 | 0.19 |
| Dividend Yield | — | — |